Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society
British Journal of Dermatology · 2023
DOI: 10.1093/bjd/ljac137 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von Matthew A Pimentel und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Oregon Health and Science University, Portland, OR, USA. Hauptthemen laut MEDLINE: Pyoderma Gangrenosum, Dermatology, Colitis, Ulcerative. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
https://doi.org/10.1093/bjd/ljac137 Dear Editor, Pyoderma gangrenosum (PG) is an ulcerative inflammatory condition that typically affects the lower extremities.1 While this disease can result in significant morbidity and mortality, there is currently no standard for defining PG severity or the clinical features determining advanced disease that necessitate more aggressive management. To address this practice gap, a systematic review of existing measures of severity was performed, followed by a Delphi exercise of clinical experts and patients to reach consensus on the clinical features that are critical for defining PG severity. The consensus outcomes will aid in developing a PG-specific severity tool. Institutional Review Board (IRB) approval was received from the Oregon Health & Science University IRB Office. The data underlying this article will be shared upon reasonable request to the corresponding author. Ovid MEDLINE and the Cochrane Library were searched for all English-language article types from January 2000 to June 2021. The Grading of Recommendation Assessment, Development, and Evaluation system was used to evaluate each article. Experts received a summary of the literature review (with level of evidence) before evaluating levels of appropriateness. Three rounds of consensus-building exercises exploring 32 clinical features were administered to PG experts within the Medical Dermatology Society (MDS). We define an expert as a dermatologist who has cared for ≥ 20 patients with PG, similar to parameters used for other rare dermatological diseases (median of 40 patients with PG cared for at the time of study).2 Of the 27 invited experts, 23 completed round 1, followed by 21 and 20 in rounds 2 and 3, respectively. Features that remained uncertain continued onto subsequent rounds of voting. Following round 1, 18 of 20 invited patients with PG (diagnosed with PARACELSUS score3 > 10 from the Pyoderma Gangrenosum Study registry at Oregon Health & Science University)4 rated the importance of subjective clinical features that achieved consensus among experts to determine their validity. These data were relayed to experts in round 2. The RAND/University of California Los Angeles appropriateness method was used to evaluate each clinical feature using a rating scale (1–9) and a level of disagreement measured by a disagreement index (DI). A median appropriateness value of 6.5 ≤ median ≤ 9.0 and a DI ≤ 1 was considered ‘appropriate’. Responses with one or more missing ratings were excluded from analysis, similarly to other Delphi studies.5
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
ORCID-Profile: May M Li, Megan H Noe, Lucia Seminario-Vidal, Teri Greiling, Arturo Dominguez, Anthony P Fernandez, Alexander D Means, Nathan W Rojek, Alex G Ortega-Loayza
Förderung
- Intramural NIH HHS
Zitieren
APA
Pimentel, M. A., Li, M. M., Noe, M. H., Latour, E., Seminario-Vidal, L., Greiling, T., Shinkai, K., Hamilton, A., Alavi, A., Bolognia, J. L., Cowen, E. W., Dominguez, A., Fernandez, A. P., Fivenson, D., Huang, W. W., Madigan, L. M., Mauskar, M., Means, A. D., Nelson, C. A., …, & Ortega-Loayza, A. G. (2023). Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljac137
Vancouver
Pimentel MA, Li MM, Noe MH, Latour E, Seminario-Vidal L, Greiling T, et al. Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljac137
BibTeX
@article{Pimentel2023,
author = {Pimentel, Matthew A and Li, May M and Noe, Megan H and Latour, Emile and Seminario-Vidal, Lucia and Greiling, Teri and Shinkai, Kanade and Hamilton, Andrew and Alavi, Afsaneh and Bolognia, Jean L and Cowen, Edward W and Dominguez, Arturo and Fernandez, Anthony P and Fivenson, David and Huang, William W and Madigan, Lauren M and Mauskar, Melissa and Means, Alexander D and Nelson, Caroline A and Patsatsi, Aikaterini and Pugliese, Douglas and Rojek, Nathan W and Rosenbach, Misha and Smith, Gideon P and Swerlick, Robert A and Heffernan, Michael P and Mostaghimi, Arash and Ortega-Loayza, Alex G},
title = {Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society},
journal = {British Journal of Dermatology},
year = {2023},
doi = {10.1093/bjd/ljac137}
}
EUVIMED